• Users Online: 360
  • Print this page
  • Email this page
Year : 2021  |  Volume : 12  |  Issue : 3  |  Page : 239-245

IMPACT India: A novel approach for optimum diabetes care

1 Department of Medicine and Department of Endocrinology, Pondicherry Institute of Medical Sciences, Pondicherry, Tamil Nadu, India
2 Dr Mohan’s Diabetes Specialities Centre, Madras Diabetes Research Foundation, Chennai, Tamil Nadu, India
3 Joshi Clinic, Lilavati Hospital Mumbai, Maharashtra, India
4 Endocrinology Department, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India
5 Centre for Diabetes and Endocrine Care, Srinagar, Jammu and Kashmir, India
6 Bharti Hospital and BRIDE, Karnal, Haryana, India
7 Chellaram Diabetes Institute, Pune, Maharashtra, India
8 Diabetes Care and Research Centre, Patna, Bihar, India
9 Max Healthcare, New Delhi, India
10 Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Dr. Nikhil Tandon
Department of Endocrinology, All India Institute of Medical Sciences, Sri Aurobindo Marg, Ansari Nagar East, New Delhi, Delhi.
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JOD.JOD_100_20

Rights and Permissions

India has the second largest population with diabetes mellitus in the world. Long-term, uncontrolled diabetes is associated with increased microvascular and macrovascular (commonly cardiovascular) complications and death. The large burden of uncontrolled diabetes in India could be because of lack of treatment adherence, limited access to laboratory testing, lack of physical activity, and poor dietary habits. This creates a compelling need for a greater involvement of healthcare professionals (HCPs) in improving societal awareness and regular monitoring of glycemic control, which is limited in patient outreach programs. IMPACT India, launched in November 2018, is a diabetes control program with a three-pronged approach aimed at creating an impact at the level of HCPs, society, and individuals living with diabetes. The India Diabetes Care Index (iDCI®), a quarterly aggregate index of glycated hemoglobin, fasting plasma glucose (FPG), and postprandial plasma glucose (PPG), forms the backbone of IMPACT India. The program uses iDCI® to evaluate glycemic control at periodic intervals, sensitize HCPs about the glycemic control status, and optimize diabetes care by escalating pharmacotherapy including insulin whenever required. Societal awareness will be created by social media to achieve actionable awareness based on the iDCI® reports. At baseline (January 2018 to June 2018), the database (2.39 million) revealed an average glycated hemoglobin of 8.56%, FPG of 172 mg/dL, and PPG of 253 mg/dL. Also, 74% of the patients had HbA1c >7% and FPG >130 mg/dL and >83% of the patients had PPG >160 mg/dL. The IMPACT India program aims to positively impact diabetes care in India by achieving at least 1% glycated hemoglobin reduction in 1000 days.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded125    
    Comments [Add]    

Recommend this journal